Correlation of metabolic characteristics with maternal, fetal and placental asprosin in human pregnancy.

Thorben HoffmannYousef Ashraf Tawfik MorcosRuth JanoschekEva-Maria TurnwaldAntje GerkenAnnette MüllerGerhard SengleJörg DötschSarah AppelEva Hucklenbruch-Rother

Published in: Endocrine connections (2022)

Asprosin could potentially act as a biomarker and contribute to the clinical manifestation of pregnancy complications associated with maternal obesity.

Keyphrases

pregnancy outcomes
birth weight
pregnant women
endothelial cells
preterm birth
weight gain
metabolic syndrome
weight loss
induced pluripotent stem cells
risk factors
pluripotent stem cells
body mass index
skeletal muscle